What it sells
Automates chronic disease care with regulated AI
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospital system and medical group executives, plus payers.
Trigger: what makes them buy now?
Clinician capacity limits in chronic care; wants to scale remote patient care without adding headcount.
Workflow: what inputs become what output?
Clinical Intelligence tracks vitals, symptoms, medications and engagement, flags risk, and AI agents equip a nurse-practitioner-led care team to act between visits, embedded in the health system EMR.
Economics: what it saves and how it charges
Designed for positive margin under RPM and APCM reimbursement and to cut total cost of care in value-based contracts; claims 20+ health systems.
Distribution: how it reaches customers
UnverifiedPartnership-led direct sales to health systems, payers and medical groups.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-06-23 | — | $100M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.